Research and Development

VBPL R&D forms backbone of our operations with almost 10% company turnover being invested towards strengthening research. Our R&D is focused towards developing Biological therapeutics, Recombinant therapeutics, Monoclonal Antibodies, Plasma derived products and Small molecules.

VBPL R&D is enlightened with highly qualified, committed and intellectual team who can transform discoveries into highest quality therapeutic products. Our core strength lies in our ability to excel in developing generics and technologically complex products through focused team in formulation, process chemistry and analytical development. We have capability to develop quality products within established timeline at low cost and without compromising on quality.


VBPL Scientists works closely with Business Development team to generate innovative concepts and ideas. As we focused on developing new technologies we continuously monitor research efficiency. Our R&D productivity ranks among brightest R&D facilities in India.

R&D team aids the company in staying competitive with others in the industry. The department research and analyze the products and new trends within the industry. This research aids the department in developing and updating the products created by the company. The team helps by directing the future of the company based on the information it provides and products it creates.

With extensive experience in producing large scale Plasma derived Immunoglobulins, VBPL is developing expertise and building facilities to support the production and testing of Recombinant proteins and Monoclonal Antibodies (MAbs).